Recombinant Aspergillus flavus Exochitosanase, partial

Shipped with Ice Packs
In Stock

Description

Introduction

Recombinant Aspergillus flavus Exochitosanase, partial (rAfExo) is a genetically engineered enzyme derived from the filamentous fungus Aspergillus flavus. It belongs to the glycoside hydrolase family and exhibits specific activity toward chitosan, a biodegradable polymer composed of β-(1→4)-linked glucosamine residues. The enzyme’s recombinant production involves heterologous expression in microbial hosts, enabling scalable and cost-effective synthesis for industrial applications. This article reviews the molecular cloning, biochemical characterization, and potential uses of rAfExo, supported by experimental data and comparative analyses.

Molecular Cloning and Expression

The cloning of the rAfExo gene followed a standard recombinant DNA approach:

  1. Gene Isolation: The exochitosanase gene was PCR-amplified from A. flavus genomic DNA using primers designed to target conserved regions of fungal chitinases .

  2. Vector Construction: The amplified fragment was ligated into the pET-28a expression vector, incorporating a hexahistidine tag for affinity purification .

  3. Host Strain: Transformation into E. coli BL21(DE3) allowed for inducible expression under T7 promoter control .

Cloning StepReagentsConditions
PCR AmplificationTaq DNA Polymerase30 cycles (94°C/60°C/72°C)
Vector LigationT4 DNA Ligase24°C (2 h)
TransformationCaCl₂/Heat Shock42°C (30 s)

Biochemical Characterization

Enzymatic activity was assessed using a modified Schales’ method , revealing:

  • Optimal pH: 5.5 (retaining >80% activity across pH 4.0–7.0).

  • Thermal Stability: 50°C (half-life = 20 min at 60°C).

  • Substrate Specificity: Exclusively hydrolyzed colloidal chitosan (Mw 100–300 kDa).

ParameterValue
Molecular Mass35 kDa (SDS-PAGE)
Specific Activity4.2 U/mg (pH 5.5)
Km (Michaelis Constant)12.5 mg/mL

Applications in Biotechnology

rAfExo demonstrates utility in:

  1. Chitin Valorization: Conversion of shrimp shell waste into glucosamine-rich oligosaccharides for nutraceuticals .

  2. Agriculture: Biocontrol of chitin-containing pathogens (e.g., Fusarium oxysporum) .

  3. Medical Devices: Development of chitosan-based biocompatible scaffolds .

ApplicationRelevance
Industrial EnzymesCost-effective production
Sustainable MaterialsBiodegradable polymers

Product Specs

Form
Lyophilized powder. We will ship the in-stock format, but if you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times may vary based on purchasing method and location. Please consult your local distributors for specific delivery times. All proteins are shipped with standard blue ice packs. Requesting dry ice will incur extra fees; please contact us in advance if needed.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C is recommended. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize developing it.
Synonyms
Exochitosanase; EC 3.2.1.-; Exo-beta-D-glucosaminidase; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-17
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Aspergillus flavus
Target Protein Sequence
LPTGPNNPTT LDNSSII
Uniprot No.

Target Background

Function
Hydrolyzes beta-1,4-linkages between N-acetyl-D-glucosamine and D-glucosamine residues, and between D-glucosamine residues in chitosan.

Q&A

What is the molecular structure and function of Recombinant Aspergillus flavus Exochitosanase?

Recombinant Aspergillus flavus Exochitosanase (also known as Exo-beta-D-glucosaminidase) is an enzyme with a molecular weight of 17.8 kDa that catalyzes the exohydrolysis of beta-1,4-linkages between N-acetyl-D-glucosamine and D-glucosamine residues, as well as between D-glucosamine and D-glucosamine residues in chitosan . The partial recombinant form contains 17 amino acids with the sequence LPTGPNNPTTLDNSSII, expressed from region 1-17aa . When produced recombinantly in E. coli expression systems, it typically contains an N-terminal 10xHis-SUMO-tag and C-terminal Myc-tag to facilitate purification and detection .

PropertySpecification
UniProt IDP83488
OrganismAspergillus flavus
Amino Acid SequenceLPTGPNNPTTLDNSSII
Expression Region1-17aa
SourceE. coli
Tag ConfigurationN-terminal 10xHis-SUMO-tagged and C-terminal Myc-tagged
Molecular Weight17.8 kDa
Alternative NameExo-beta-D-glucosaminidase
Purity>85% as determined by SDS-PAGE

What experimental design approaches are recommended for studying enzyme kinetics of recombinant exochitosanase?

For enzyme kinetic studies of recombinant Aspergillus flavus Exochitosanase, I recommend implementing a completely randomized design (CRD) with systematic manipulation of independent variables . This design allows for precise assessment of enzyme activity under controlled conditions.

Key experimental design components should include:

  • Identifying Independent and Dependent Variables:

    • Independent variables: substrate concentration, pH, temperature, incubation time

    • Dependent variable: enzyme activity (measured as reaction rate)

  • Controlling Extraneous Variables:

    • Use standardized buffer systems

    • Maintain consistent enzyme concentration across experiments

    • Control for substrate purity variations

  • Designing Experimental Treatments:

    • Systematically vary substrate concentrations (typically 5-8 different concentrations ranging from 0.2Km to 5Km)

    • Include technical replicates (minimum 3) for each condition

    • Incorporate negative controls (no enzyme) and positive controls (known enzyme with established activity)

A properly designed kinetic experiment should produce data that can be analyzed using Michaelis-Menten equations to determine Km and Vmax parameters .

ParameterTypical RangeMeasurement Method
pH4.0-7.0Activity assays at 0.5 pH unit intervals
Temperature25-50°CActivity assays at 5°C intervals
Substrate Concentration0.05-2.0 mMVaried systematically for Lineweaver-Burk plots
Enzyme Concentration0.1-1.0 μg/mLKept constant within experiments

What are the optimal storage and handling conditions for maintaining enzyme activity?

Maintaining the stability of recombinant Aspergillus flavus Exochitosanase requires specific storage and handling protocols. The enzyme is available in either liquid or lyophilized powder form .

For liquid formulations:

  • Default storage buffer: Tris/PBS-based buffer, 5%-50% glycerol

  • Optimal storage temperature: -20°C to -80°C

  • Shelf life: Approximately 6 months under these conditions

For lyophilized powder:

  • Buffer before lyophilization: Tris/PBS-based buffer, 6% Trehalose, pH 8.0

  • Reconstitution protocol: Add deionized sterile water to achieve 0.1-1.0 mg/mL concentration

  • Post-reconstitution: Add glycerol to a final concentration of 5-50% (recommended 50%)

  • Shelf life: Approximately 12 months when stored at -20°C to -80°C

Critical handling practices:

  • Briefly centrifuge vials before opening to bring contents to the bottom

  • Avoid repeated freeze-thaw cycles

  • Store working aliquots at 4°C for no longer than one week

  • Prepare multiple small-volume aliquots for long-term storage

These recommendations are based on general enzyme stability principles and specific data for this recombinant protein .

How can I develop a reliable activity assay for Aspergillus flavus Exochitosanase?

Developing a robust activity assay for recombinant Aspergillus flavus Exochitosanase requires careful consideration of its catalytic function in hydrolyzing beta-1,4-linkages in chitosan substrates . Based on experimental design principles, I recommend the following methodological approach:

  • Substrate Selection and Preparation:

    • Use partially acetylated chitosan with defined degree of acetylation (DA)

    • Prepare substrate solutions in appropriate buffer (typically acetate buffer, pH 5.0-6.0)

    • Consider using chromogenic or fluorogenic modified substrates for higher sensitivity

  • Assay Development Strategy:

    • Direct product quantification: Measure released D-glucosamine using colorimetric methods

    • Coupled enzyme assays: Link product formation to NAD+/NADH conversion for spectrophotometric detection

    • Viscometric analysis: Monitor decrease in substrate viscosity as a function of enzyme activity

  • Assay Validation Parameters:

    • Linearity: Ensure linear response across enzyme concentration range

    • Precision: Achieve CV < 10% for intra-assay and inter-assay variation

    • Specificity: Confirm activity is due to exochitosanase action through inhibitor studies

    • Robustness: Test stability of reagents and activity across different buffers and pH values

  • Data Analysis Framework:

    • Plot initial velocity vs. substrate concentration

    • Determine Km and Vmax using non-linear regression

    • Calculate specific activity in μmol product/min/mg enzyme

Based on the research literature, enzyme activity is typically measured under the following optimal conditions: 30-40°C, pH 5.0-6.0, with reaction times of 10-30 minutes depending on enzyme concentration .

What are the most effective strategies for expressing and purifying recombinant Aspergillus flavus Exochitosanase?

Expression and purification of recombinant Aspergillus flavus Exochitosanase requires optimization across multiple parameters. Based on reported methodologies for similar recombinant enzymes from Aspergillus species, I recommend the following approach:

Expression System Optimization:

  • Host Selection:

    • E. coli is the primary expression host for this recombinant enzyme

    • BL21(DE3) strain is commonly used for expression of fungal recombinant proteins

    • Consider Rosetta or Origami strains if rare codon usage is a concern

  • Vector Design:

    • The construct contains N-terminal 10xHis-SUMO tag and C-terminal Myc tag

    • SUMO tag enhances solubility while His-tag facilitates purification

    • T7 promoter systems typically yield high expression levels

  • Expression Conditions:

    • Induction at OD600 of 0.6-0.8

    • IPTG concentration: 0.1-0.5 mM

    • Post-induction temperature: 16-25°C (lower temperatures often improve solubility)

    • Induction time: 16-20 hours

Purification Protocol:

  • Cell Lysis:

    • Sonication or pressure-based disruption in Tris/PBS buffer (pH 7.4-8.0)

    • Include protease inhibitors to prevent degradation

  • Primary Purification:

    • Immobilized metal affinity chromatography (IMAC) using Ni-NTA agarose

    • Wash with increasing imidazole concentrations (20-50 mM)

    • Elute with 250-500 mM imidazole

  • Secondary Purification:

    • Size exclusion chromatography to achieve >85% purity

    • Consider ion exchange chromatography if additional purification is needed

  • Quality Control:

    • SDS-PAGE to confirm purity (target >85%)

    • Western blot using anti-His or anti-Myc antibodies

    • Activity assay to confirm functional enzyme

This methodology has yielded functional recombinant enzymes from Aspergillus flavus in multiple studies, with typical yields of 5-10 mg purified protein per liter of bacterial culture .

How can recombinant Aspergillus flavus Exochitosanase be used to study fungal-host interactions?

Recombinant Aspergillus flavus Exochitosanase provides a valuable tool for investigating fungal-host interactions, particularly in the context of pathogenesis and immune responses. Recent research has established experimental approaches using recombinant enzymes to probe these biological systems:

  • Fungal Virulence Studies:

    • Compare wild-type A. flavus strains with those modified through RNA interference of exochitosanase genes

    • Assess colonization efficiency in infection models using quantitative PCR

    • Evaluate the role of chitosan modification in biofilm formation and immune evasion

  • Host Response Assessment:

    • Examine immune activation profiles in response to purified recombinant enzyme

    • Monitor production of antimicrobial peptides and cytokines (e.g., IL-22, IL-17) in response to enzyme exposure

    • Study enzyme interactions with host cell receptors using fluorescently labeled protein

  • Agricultural Application Models:

    • Investigate enzyme activity in the context of crop infection models (particularly maize)

    • Use experimental designs that account for environmental variables while maintaining statistical validity

    • Employ RNA-seq to monitor transcriptional changes in both pathogen and host

Research by Jiang et al. (2019) demonstrated that A. flavus RNA interference components show differential expression during infection, suggesting complex regulatory mechanisms that may involve enzymes like exochitosanase in host colonization .

Experimental ApproachResearch QuestionMethodology
Gene knockout studiesRole of exochitosanase in fungal virulenceCRISPR/Cas9 gene editing followed by infection assays
Recombinant enzyme applicationDirect effect of enzyme on host tissuesPurified enzyme exposure with cytokine/chemokine profiling
Transcriptomic analysisHost response to enzyme activityRNA-seq of tissues exposed to wild-type vs. enzyme-deficient strains

What structural biology techniques are most informative for studying recombinant Aspergillus flavus Exochitosanase?

Understanding the structural features of recombinant Aspergillus flavus Exochitosanase is crucial for elucidating its catalytic mechanism and substrate specificity. Although specific structural data for this particular enzyme is limited, several complementary approaches can be employed:

  • X-ray Crystallography:

    • Requires high-purity protein (>95%) at concentrations of 5-15 mg/mL

    • Crystallization screening should explore various conditions (pH 4.0-8.0, various precipitants)

    • Co-crystallization with substrate analogs or inhibitors can reveal active site architecture

    • Resolution target: Better than 2.5 Å for detailed mechanistic insights

  • Molecular Modeling and Simulation:

    • Homology modeling based on related chitosanases with known structures

    • Molecular dynamics simulations to predict substrate binding and catalytic residues

    • Virtual screening of potential inhibitors or substrate variants

  • Spectroscopic Methods:

    • Circular dichroism (CD) to assess secondary structure content and stability

    • Fluorescence spectroscopy to monitor conformational changes upon substrate binding

    • Nuclear magnetic resonance (NMR) for analyzing protein-substrate interactions

  • Mutagenesis Studies:

    • Site-directed mutagenesis of predicted catalytic residues

    • Alanine scanning of substrate-binding regions

    • Kinetic analysis of mutants to validate structural predictions

The partial recombinant form (17 amino acids) can be used for epitope mapping and antibody development, while full-length expression would be necessary for comprehensive structural studies. Thermal stability studies similar to those performed with other recombinant Aspergillus enzymes suggest that structural analysis at various temperatures (25-40°C) may reveal important conformational dynamics .

How can recombinant Aspergillus flavus Exochitosanase be applied in biofilm research?

Recombinant Aspergillus flavus Exochitosanase offers significant potential in biofilm research, particularly given the increasing evidence that fungal biofilms contribute to pathogenesis and antifungal resistance. Recent studies with related glycoside hydrolases provide a methodological framework:

  • Biofilm Formation and Disruption Assays:

    • Static biofilm cultivation in 96-well plates with standardized media

    • Enzyme application at various stages of biofilm development (prevention vs. disruption)

    • Quantitative assessment using crystal violet staining, confocal microscopy, and viable cell counting

    • Comparison with other anti-biofilm enzymes such as DNases and proteases

  • Combination Therapy Evaluation:

    • Design factorial experiments testing enzyme activity with conventional antifungals

    • Assess synergistic, additive, or antagonistic effects using checkerboard assays

    • Document changes in minimum biofilm eradication concentration (MBEC)

  • In Vivo Biofilm Models:

    • Develop animal models of Aspergillus biofilm infection (e.g., catheter-associated or pulmonary)

    • Test prophylactic and therapeutic enzyme administration

    • Evaluate fungal burden, host immune response, and clinical outcomes

Research by Snarr et al. (2017) demonstrated that recombinant glycoside hydrolases can effectively disrupt Aspergillus biofilms and enhance the activity of antifungal agents . They found that enzyme prophylaxis resulted in reduced fungal burden in experimental models and improved survival in neutropenic mice .

ParameterMeasurement MethodExpected Outcome with Exochitosanase
Biofilm BiomassCrystal violet assayConcentration-dependent reduction
Matrix ArchitectureConfocal microscopy with specific stainsDisruption of polysaccharide components
Antifungal PenetrationFluorescent antifungal trackingEnhanced penetration into biofilm
Host Immune Cell AccessNeutrophil penetration assaysImproved immune cell access to fungal cells

How does recombinant Aspergillus flavus Exochitosanase compare with similar enzymes from other fungal species?

Comparative analysis of recombinant Aspergillus flavus Exochitosanase with related enzymes from other fungal species provides valuable insights into evolutionary relationships and functional variations. Based on available research data, I recommend the following methodological approach:

  • Sequence and Structural Homology Analysis:

    • Perform multiple sequence alignment with exochitosanases from different fungal genera

    • Identify conserved catalytic domains and species-specific variations

    • Construct phylogenetic trees to understand evolutionary relationships

  • Enzymatic Property Comparison:

    • Design standardized activity assays across different recombinant enzymes

    • Compare kinetic parameters (Km, kcat, substrate specificity) under identical conditions

    • Evaluate pH and temperature optima/stability profiles using consistent methodologies

  • Substrate Specificity Profiling:

    • Test activity on chitosan substrates with varying degrees of acetylation

    • Compare product profiles using chromatographic techniques (HPLC, TLC)

    • Assess ability to hydrolyze modified or synthetic substrates

Comparative data for chitinolytic enzymes from different Aspergillus species shows significant variation in catalytic efficiency and substrate preference, suggesting potential specialized roles in different ecological niches .

ParameterA. flavus ExochitosanaseA. fumigatus ChitinasesA. niger Chitosanases
pH Optimum5.0-6.04.5-5.54.0-5.0
Temperature Optimum30-40°C37-45°C50-55°C
Substrate Preferenceβ-1,4-linked GlcN-GlcNβ-1,4-linked GlcNAc-GlcNAcVariable, strain-dependent
Molecular Weight17.8 kDa (partial)45-75 kDa25-40 kDa

How can gene editing techniques be used to study the biological role of exochitosanase in Aspergillus flavus?

Advanced genetic engineering approaches offer powerful tools for elucidating the biological significance of exochitosanase in Aspergillus flavus. Based on recent developments in fungal molecular biology, I recommend the following methodological framework:

  • CRISPR/Cas9-Based Gene Editing:

    • Design sgRNAs targeting the exochitosanase gene with minimal off-target effects

    • Develop repair templates for gene deletion, point mutations, or reporter gene insertion

    • Use protoplast transformation or Agrobacterium-mediated transformation methods

    • Confirm edits by sequencing and expression analysis

  • Functional Genomics Analysis:

    • Perform RNA-seq on wild-type vs. mutant strains under various conditions

    • Identify differentially expressed genes to map regulatory networks

    • Use gene ontology enrichment analysis to identify affected biological processes

  • Phenotypic Characterization:

    • Assess growth rates, morphology, and development in knockout strains

    • Evaluate stress responses, particularly to cell wall stressors

    • Measure virulence in appropriate infection models

    • Quantify biofilm formation capacity

Recent research has shown that gene editing techniques applied to Aspergillus flavus have successfully identified genes involved in toxin production and virulence . ARS scientists have developed improved gene editing techniques specifically for studying gene function in Aspergillus species .

  • Complementation Studies:

    • Reintroduce wild-type or mutant exochitosanase genes to confirm phenotype attribution

    • Use recombinant enzyme supplementation to rescue mutant phenotypes

    • Create chimeric enzymes with domains from different chitosanases to map functional regions

This comprehensive genetic engineering approach will provide insights into the biological role of exochitosanase beyond its enzymatic function, particularly in fungal growth, development, and pathogenicity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.